Sitemap

Blog Articles

• From Detection to Decision: Risk-Based Immunogenicity Testing (April 29, 2026)
• From Discovery to Decision: Building a Fit-for-Purpose Proteomics Strategy for Clinical Development (April 9, 2026)
• Protein Degraders: Small Molecules Taking out the Trash (March 4, 2026)
• A Practical Guide to Biomarkers for Clinical Development (February 3, 2026)
• How to Accelerate Preclinical Trials with Flow Cytometry (January 30, 2026)
• Navigating IVDR in Clinical Trials: What’s Changed, and Why It Matters (January 29, 2026)
• Where Does Bioanalysis Fit into Drug Discovery Pipelines? (January 8, 2026)
• EBF OS 2025: My Key Highlights (December 10, 2025)
• S-Pindolol: The Fight Against Cancer Cachexia (November 13, 2025)
• The Silence of the Genes: Unlocking Antisense Oligonucleotide Therapies for the Renin-Angiotensin-Aldosterone System (October 22, 2025)
• From Signals to Systems: Olink Proteomics as a Cornerstone of Synexa’s Biomarker Strategy (October 14, 2025)
• GMP Grade Ligand Binding and Potency Assays – Frequently Asked Questions (September 11, 2025)
• Validating Immunity: How ELISpot Data Shaped the AELIX-003 HIV Cure Trial (July 2, 2025)
• From Pathways to Proof: Targeted Phosphoproteomics and PTM Analysis with LC-MS/MS (June 18, 2025)
• Establishing Biosimilarity: Regulatory and Scientific Expectations (June 5, 2025)
• Why The Future Of Precision Medicine Will Be Defined By The Quality And Strategy Of Biomarker Signatures (May 15, 2025)
• Radiopharmaceutical Drug Development: A Bioanalytical Lab Perspective (May 8, 2025)
• Building a bioanalytical workflow for a vaccine study: The key assays and considerations (March 12, 2025)
• Quantitative Analysis of Oligonucleotides: An out of the box LC-MS/MS approach (March 5, 2025)
• The Next Frontier for CAR T-Cell Therapy: Shifting Gears to Autoimmune Conditions (February 18, 2025)
• Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials (October 18, 2024)
• Allogeneic CAR T cell therapies: A major step forward (October 9, 2024)
• A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology (September 17, 2024)
• The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers (September 5, 2024)
• The STING in the tail: How our own defense mechanisms to infection may be working against us (August 29, 2024)
• Falling drug approval rates: What should we be doing differently? (August 6, 2024)
• Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer (June 7, 2024)
• World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies (May 30, 2024)
• World Preeclampsia Day 2024: A spotlight on the neurological consequences (May 17, 2024)
• Primary Immunodeficiency Week: The promise of gene therapy (April 25, 2024)
• Primary Immunodeficiency Week: A complex landscape of genetic disorders (April 23, 2024)
• From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day (April 5, 2024)
• Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs (March 20, 2024)
• Cardiovascular complications in chronic kidney disease: New biomarkers and treatment (March 13, 2024)
• Modelling Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A rare autoimmune disease (February 29, 2024)
• World Cancer Day 2024: Closing the gap (February 5, 2024)
• Mycobacterium leprae: The lazy cousin to Tuberculosis  (January 29, 2024)
• The criticality of early detection of pre-eclampsia: New biomarkers (January 24, 2024)
• Top 3 Biotech Trends in 2024 | Dr. Caroline Beltran  (January 9, 2024)
• Top 3 Biotech Trends in 2024 | Dr. Nicholas Woudberg (January 8, 2024)
• Bioanalytical Strategies for Cell Therapy Clinical Trials (December 6, 2023)
• AI-assisted pathology for precision medicine: Are we there yet? (October 5, 2023)
• Uncovering tissue complexity through spatial biology (September 15, 2023)
• The standardization of synuclein seed amplification assays (August 30, 2023)
• Biomarkers in saliva: A novel approach to endometriosis (August 17, 2023)
• Revolutionizing Lung Cancer Treatment with CAR-T Cell Therapy (August 1, 2023)
• Advances in Autoimmune Hepatitis Biomarkers: Improving Diagnosis and Treatment Outcomes (July 28, 2023)
• Liquid biopsies: a non-invasive picture of cancer physiology (July 12, 2023)
• Challenges and Opportunities: Development of the HIV vaccine (May 18, 2023)
• Biomarkers for Dementia (May 17, 2023)
• Asthma Care for All (May 2, 2023)
• Monitoring Immune Response in Pediatric Vaccine Recipients (April 27, 2023)
• Improving the World's First Malaria Vaccine (April 26, 2023)
• Parkinson’s Disease Biomarker Assessment: New Approaches and Directions (April 11, 2023)
• The Current State of Tuberculosis Research | World TB Day (March 24, 2023)
• How Cytokine Release Assays Work in Predictive Immunotoxicology (March 10, 2023)
• Understanding the Role of Phenotypic Assays in Drug Research (February 24, 2023)
• What Biomarkers Are Used For CNS Drug Development? (February 9, 2023)
• How Immunogenomics Factors into Cell and Gene Studies (November 29, 2022)
• Using Exosomes As Clinical Biomarkers (November 18, 2022)
• A Brief Introduction To Novel Modalities (November 2, 2022)
• Enhancing PCR Molecular Diagnostics Using Immunoassays (October 7, 2022)
• How to Measure Bacteriophages in Clinical Studies for Antimicrobial Agents (September 30, 2022)
• What are Immune Checkpoint Inhibitors? (August 26, 2022)
• Fibrosis and SMAD signalling (April 22, 2022)
• Lipids as Biomarkers of Brain Disorders (March 24, 2022)
• Synexa raises awareness for Rare Diseases Day (February 28, 2022)
• Behind The Wave: The Importance of Post-Market Surveillance and its Pertinence to the COVID-19 Pandemic (May 20, 2021)
• The Biomarker Association between Depression and Vascular Disease (February 15, 2021)
• Infertility and the importance of the endometrial immune balance (February 15, 2021)
• Immunogenicity 101: Antidrug Antibodies, Neutralising Antibodies, and everything in between (January 20, 2021)
• Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis (September 18, 2020)
• Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays (September 18, 2020)
• Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain (September 18, 2020)
• The prospect of immunotherapy for combating Alzheimer’s disease (September 18, 2020)
• Rapid expansion of Treg cells protects from collateral colitis following a viral trigger (September 18, 2020)
• Immune biomarkers in depression (July 24, 2020)
• Faecal Calprotectin as a biomarker in Crohn’s disease (July 24, 2020)
• Immune checkpoint inhibitors and MDSCs (July 16, 2020)
• Potential concussion biomarkers discovered in circulating blood after brain injury (July 16, 2020)
• Complement C4 Genes and Sex-Biased Disease Susceptibility (July 16, 2020)
• A unifying expression signature for SLE (July 16, 2020)